ISSUE #11 Oct 1, 2025

The Global IR@SIF 2025, co-hosted by KoreaBIO and Invest Seoul during the Seoul Investors Forum (SIF) on September 22, was a great success. Thanks to everyone who joined!


KoreaBIO, supported by the Ministry of Trade, Industry and Energy and Gyeonggi-do, held the '2025 BioHealth Companies Job Fair,' which drew 270 attendees and strong interest.
∎ Alteogen "FDA Approves Subcutaneous Version of Keytruda" - PharmEdaily
∎ Celltrion buys Eli Lilly’s New Jersey plant for $330 million - The Korea Economic Daily
∎ Celltrion's chronic idiopathic urticaria therapy Omlyclo: a first-mover in Europe - THE BIO
∎ Celltrion wins Japan approval for Actemra biosimilar - KBR
∎ Hanmi Pharmaceutical Exports 'Ensacvida' Technology to Gilead in $34.5 Million Deal - The Asia Business Daily
∎ Korea's GCCL partners with Frontage Labs to strengthen global clinical trial capabilities - BioSpectrum Asia
∎ PanGen Biotech to Renew its GMP Certification in Turkiye “Accelerating Global EPO Biosimilar Business” - THE BIO
∎ GC Biopharma launches plasma center in Laredo, U.S., moving early to outpace ALYGLO's expansion - THE BIO
∎ GI Innovation's immuno-oncology candidate 'GI 102' granted fast-track designation by U.S. FDA - THE BIO
∎ Korean traditional medicine to broaden footprint in Middle East - Aju Press
∎ LG Household & Health Care and Blumeige Join Forces to Advance Skin Aging Research - Hinews
∎ Lunit and Agilent join hands for AI-powered companion diagnostics - BioSpectrum Asia
∎ Kakao Healthcare, Canadian firm team up on AI health - The Korea Times
∎ K-Bio Ushering in the Era of Profit-Generating Industry - The Asia Business Daily
∎ AbClon's next-generation CAR-T candidate Nespe-cel designated as fast-track treatment by MFDS - THE BIO
∎ ABL Bio Secures Domestic Patent for 4-1BB Monoclonal Antibody - The Asia Business Daily
∎ Boryung Bets on Biosimilars as Oncology Growth Engine - Hitnews
∎ Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business - BioSpace
∎ Huons Joins National Project to Secure Orphan and Essential Drugs - Hitnews
∎ Ildong Pharmaceutical Group's once-daily obesity drug achieves 9.9% average weight loss at maximum dose in Phase 1 topline trials - THE BIO
∎ Inside 6-year ginseng harvest for Jung Kwan Jang - The Korea Times
∎ Arocell raises 4 billion won from Hanwha and VC firms to expand bio‑beauty offerings - ChosunBiz
∎ HD Hyundai Oilbank begins Korea’s first SAF supply - Pulse
∎ KAIST turns 3D printing upside down to make custom brain chip - Aju Press
∎ Korean startup Sky Labs unveils ring-type cuffless blood pressure monitor - BioSpectrum Asia
✨Don't miss BIX 2025✨
2 weeks to go until
BIOPLUS-INTERPHEX KOREA 2025!
Check out our highlighted sessions
(by KoreaBIO) and more info below 😎
Explore More
📰
Join our press list
Get KoreaBIO updates
& media resources
💬
Share Your thoughts!
How was your letter today?
✉️
Korean Newsletter
Daily biotech news from Korea and around the world
— in Korean
Explore More
KoreaBIO (Korea Biotechnology Industry Organization)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
+82-31-628-0037
수신거부 Unsubscribe